BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 37278349)

  • 1. Liraglutide ameliorates oxidized LDL-induced endothelial dysfunction by GLP-1R-dependent downregulation of LOX-1-mediated oxidative stress and inflammation.
    Ying W; Meiyan S; Wen C; Kaizu X; Meifang W; Liming L
    Redox Rep; 2023 Dec; 28(1):2218684. PubMed ID: 37278349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginkgolide B ameliorates oxidized low-density lipoprotein-induced endothelial dysfunction via modulating Lectin-like ox-LDL-receptor-1 and NADPH oxidase 4 expression and inflammatory cascades.
    Feng Z; Yang X; Zhang L; Ansari IA; Khan MS; Han S; Feng Y
    Phytother Res; 2018 Dec; 32(12):2417-2427. PubMed ID: 30136446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procyanidin B2 alleviates oxidized low-density lipoprotein-induced cell injury, inflammation, monocyte chemotaxis, and oxidative stress by inhibiting the nuclear factor kappa-B pathway in human umbilical vein endothelial cells.
    Yuan L; Fan L; Zhang Z; Huang X; Liu Q; Zhang Z
    BMC Cardiovasc Disord; 2024 Apr; 24(1):231. PubMed ID: 38679696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways.
    Yao Y; Wang Y; Zhang Y; Liu C
    Lipids Health Dis; 2017 Apr; 16(1):77. PubMed ID: 28407763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GLP-1 receptor agonist liraglutide protects against oxidized LDL-induced endothelial inflammation and dysfunction via KLF2.
    Yue W; Li Y; Ou D; Yang Q
    IUBMB Life; 2019 Sep; 71(9):1347-1354. PubMed ID: 30969479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol extract of propolis protects endothelial cells from oxidized low density lipoprotein-induced injury by inhibiting lectin-like oxidized low density lipoprotein receptor-1-mediated oxidative stress.
    Fang Y; Li J; Ding M; Xu X; Zhang J; Jiao P; Han P; Wang J; Yao S
    Exp Biol Med (Maywood); 2014 Dec; 239(12):1678-87. PubMed ID: 24962173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells.
    Dai Y; Mercanti F; Dai D; Wang X; Ding Z; Pothineni NV; Mehta JL
    Biochem Biophys Res Commun; 2013 Jul; 437(1):62-6. PubMed ID: 23806684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginkgolide B Mediated Alleviation of Inflammatory Cascades and Altered Lipid Metabolism in HUVECs via Targeting PCSK-9 Expression and Functionality.
    Wang G; Liu Z; Li M; Li Y; Alvi SS; Ansari IA; Khan MS
    Biomed Res Int; 2019; 2019():7284767. PubMed ID: 31281844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized low-density lipoprotein attenuated desmoglein 1 and desmocollin 2 expression via LOX-1/Ca(2+)/PKC-β signal in human umbilical vein endothelial cells.
    Li YB; Zhang QH; Chen Z; He ZJ; Yi GH
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):380-6. PubMed ID: 26498522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
    Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
    J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
    Zhao W; Ma G; Chen X
    Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin Inhibits Oxidized Low Density Lipoprotein Uptake in Human Umbilical Vein Endothelial Cells via mTOR/NF-κB/LOX-1 Pathway.
    Zhou YD; Cao XQ; Liu ZH; Cao YJ; Liu CF; Zhang YL; Xie Y
    PLoS One; 2016; 11(1):e0146777. PubMed ID: 26752047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway.
    Ou HC; Chou WC; Hung CH; Chu PM; Hsieh PL; Chan SH; Tsai KL
    Environ Toxicol; 2019 Jul; 34(7):825-835. PubMed ID: 30963716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of oxidized-LDL receptor-1 (LOX1) contributes to the antiatherosclerosis effect of oleanolic acid.
    Jiang Q; Wang D; Han Y; Han Z; Zhong W; Wang C
    Int J Biochem Cell Biol; 2015 Dec; 69():142-52. PubMed ID: 26510581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide ameliorates palmitate-induced oxidative injury in islet microvascular endothelial cells through GLP-1 receptor/PKA and GTPCH1/eNOS signaling pathways.
    Le Y; Wei R; Yang K; Lang S; Gu L; Liu J; Hong T; Yang J
    Peptides; 2020 Feb; 124():170212. PubMed ID: 31770577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginkgolide B reduces LOX-1 expression by inhibiting Akt phosphorylation and increasing Sirt1 expression in oxidized LDL-stimulated human umbilical vein endothelial cells.
    Ma L; Liu X; Zhao Y; Chen B; Li X; Qi R
    PLoS One; 2013; 8(9):e74769. PubMed ID: 24069345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of CPEB1 protects against oxidized LDL-induced endothelial apoptosis and inflammation though SIRT1/LOX-1 signalling pathway.
    Xu K; Xiwen Liu ; Ren G; Yin D; Guo S; Zhao Y
    Life Sci; 2019 Dec; 239():116874. PubMed ID: 31521690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway.
    Ke J; Liu Y; Yang J; Lu R; Tian Q; Hou W; Wang G; Wei R; Hong T
    Sci Rep; 2017 Feb; 7():41085. PubMed ID: 28145471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of LOX-1 on expression of adhesion molecules induced by ox-LDL in HUVECs].
    Zhu HL; Xia M; Hou MJ; Tang ZH; Zheng PY; Ling WH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Aug; 33(8):743-7. PubMed ID: 16188066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway.
    Qian W; Cai X; Qian Q; Zhuang Q; Yang W; Zhang X; Zhao L
    Drug Des Devel Ther; 2019; 13():2579-2589. PubMed ID: 31440038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.